Poolbeg Pharma (POLB) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Sep 2021 07:00 AM
RNS
POLB001 US Patent Update
23 Aug 2021 09:06 AM
RNS
Second Price Monitoring Extn
23 Aug 2021 09:00 AM
RNS
Price Monitoring Extension
04 Aug 2021 11:30 AM
RNS
Holding(s) in Company
23 Jul 2021 01:26 PM
RNS
TR-1
19 Jul 2021 07:00 AM
RNS
Admission to AIM

Poolbeg Pharma is a biopharmaceutical company that develops and commercialises medicines for unmet medical needs, including rare and orphan diseases. Poolbeg Pharma focuses on developing medicines for areas of high unmet need, such as cancer immunotherapy-induced CRS, infectious disease, and metabolic conditions like obesity. It is listed on the stock exchange under the ticker POLB.

POLB share price launched at 11p in 2021.

 

UK 100

Latest directors dealings